Correlation Between Northwest Biotherapeutics and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Northwest Biotherapeutics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Northwest Biotherapeutics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Northwest Biotherapeutics and DiaMedica Therapeutics, you can compare the effects of market volatilities on Northwest Biotherapeutics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Northwest Biotherapeutics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Northwest Biotherapeutics and DiaMedica Therapeutics.
Diversification Opportunities for Northwest Biotherapeutics and DiaMedica Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Northwest and DiaMedica is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Northwest Biotherapeutics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Northwest Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Northwest Biotherapeutics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Northwest Biotherapeutics i.e., Northwest Biotherapeutics and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Northwest Biotherapeutics and DiaMedica Therapeutics
Given the investment horizon of 90 days Northwest Biotherapeutics is expected to under-perform the DiaMedica Therapeutics. But the otc stock apears to be less risky and, when comparing its historical volatility, Northwest Biotherapeutics is 1.06 times less risky than DiaMedica Therapeutics. The otc stock trades about -0.03 of its potential returns per unit of risk. The DiaMedica Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 158.00 in DiaMedica Therapeutics on September 4, 2024 and sell it today you would earn a total of 390.50 from holding DiaMedica Therapeutics or generate 247.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Northwest Biotherapeutics vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Northwest Biotherapeutics |
| DiaMedica Therapeutics |
Northwest Biotherapeutics and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Northwest Biotherapeutics and DiaMedica Therapeutics
The main advantage of trading using opposite Northwest Biotherapeutics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Northwest Biotherapeutics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Northwest Biotherapeutics vs. DiaMedica Therapeutics | Northwest Biotherapeutics vs. Lyra Therapeutics | Northwest Biotherapeutics vs. Centessa Pharmaceuticals PLC |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |